tiprankstipranks
Trending News
More News >
Biontech Se Sponsored Adr (GB:0A3M)
:0A3M
UK Market

BioNTech SE (0A3M) Ratios

Compare
5 Followers

BioNTech SE Ratios

GB:0A3M's free cash flow for Q4 2024 was €0.80. For the 2024 fiscal year, GB:0A3M's free cash flow was decreased by € and operating cash flow was €0.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
7.45 9.43 7.43 4.33 2.75
Quick Ratio
7.34 9.26 7.28 4.18 2.64
Cash Ratio
3.87 5.63 4.70 0.49 2.00
Solvency Ratio
-0.12 0.40 2.96 2.63 0.05
Operating Cash Flow Ratio
0.08 2.59 4.60 0.26 -0.02
Short-Term Operating Cash Flow Coverage
5.26 191.15 377.15 6.85 -1.48
Net Current Asset Value
€ 15.68B€ 16.77B€ 18.70B€ 11.14B€ 720.12M
Leverage Ratios
Debt-to-Assets Ratio
0.01 <0.01 <0.01 0.02 0.10
Debt-to-Equity Ratio
0.01 0.01 0.01 0.03 0.18
Debt-to-Capital Ratio
0.01 0.01 0.01 0.02 0.15
Long-Term Debt-to-Capital Ratio
0.01 <0.01 <0.01 0.01 0.14
Financial Leverage Ratio
1.16 1.14 1.16 1.33 1.69
Debt Service Coverage Ratio
-6.81 29.01 162.25 75.75 0.75
Interest Coverage Ratio
-104.31 1.21K 668.93 2.83K -1.27
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 0.02
Interest Debt Per Share
1.11 0.91 0.95 1.26 1.30
Net Debt to EBITDA
25.90 -10.52 -1.10 -0.09 9.23
Profitability Margins
Gross Profit Margin
80.32%84.29%73.82%79.66%-46.03%
EBIT Margin
-24.18%31.26%71.08%78.66%-29.81%
EBITDA Margin
-13.34%28.48%71.79%79.06%-21.79%
Operating Profit Margin
-47.77%18.08%73.03%80.54%-17.09%
Pretax Profit Margin
-24.63%31.06%74.83%79.29%-30.23%
Net Profit Margin
-24.18%24.36%54.50%54.24%3.15%
Continuous Operations Profit Margin
-24.18%24.36%54.50%54.24%3.15%
Net Income Per EBT
98.17%78.43%72.83%68.41%-10.43%
EBT Per EBIT
51.56%171.80%102.46%98.45%176.91%
Return on Assets (ROA)
-2.95%4.04%40.53%65.02%0.66%
Return on Equity (ROE)
-3.43%4.60%47.04%86.54%1.11%
Return on Capital Employed (ROCE)
-6.57%3.30%62.19%123.76%-4.81%
Return on Invested Capital (ROIC)
-6.44%2.58%45.21%83.78%0.50%
Return on Tangible Assets
-3.11%4.26%40.91%65.86%0.71%
Earnings Yield
-2.51%4.05%27.64%18.61%0.10%
Efficiency Ratios
Receivables Turnover
1.81 1.77 2.42 1.53 0.00
Payables Turnover
1.27 1.69 22.20 24.13 6.89
Inventory Turnover
1.91 1.68 10.31 7.68 10.99
Fixed Asset Turnover
2.32 3.93 21.08 36.47 1.48
Asset Turnover
0.12 0.17 0.74 1.20 0.21
Working Capital Turnover Ratio
0.16 0.21 1.13 3.00 0.65
Cash Conversion Cycle
105.49 208.75 169.63 270.53 -19.78
Days of Sales Outstanding
202.18 206.50 150.67 238.15 0.00
Days of Inventory Outstanding
191.03 217.67 35.40 47.51 33.23
Days of Payables Outstanding
287.72 215.42 16.44 15.13 53.01
Operating Cycle
393.21 424.17 186.07 285.66 33.23
Cash Flow Ratios
Operating Cash Flow Per Share
0.86 22.33 55.81 3.65 -0.06
Free Cash Flow Per Share
-1.02 19.39 54.31 3.02 -0.42
CapEx Per Share
1.88 2.93 1.49 0.63 0.36
Free Cash Flow to Operating Cash Flow
-1.18 0.87 0.97 0.83 7.34
Dividend Paid and CapEx Coverage Ratio
0.46 7.61 16.19 5.78 -0.16
Capital Expenditure Coverage Ratio
0.46 7.61 37.37 5.78 -0.16
Operating Cash Flow Coverage Ratio
0.82 24.52 63.98 2.95 -0.06
Operating Cash Flow to Sales Ratio
0.08 1.41 0.78 0.05 -0.03
Free Cash Flow Yield
-0.92%20.31%38.71%1.33%-0.63%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-39.76 24.69 3.62 5.37 1.03K
Price-to-Sales (P/S) Ratio
9.62 6.02 1.97 2.91 32.56
Price-to-Book (P/B) Ratio
1.36 1.13 1.70 4.65 11.45
Price-to-Free Cash Flow (P/FCF) Ratio
-108.15 4.92 2.58 75.19 -158.75
Price-to-Operating Cash Flow Ratio
127.37 4.28 2.51 62.17 -1.17K
Price-to-Earnings Growth (PEG) Ratio
0.23 -0.27 -0.27 <0.01 -9.65
Price-to-Fair Value
1.36 1.13 1.70 4.65 11.45
Enterprise Value Multiple
-46.16 10.60 1.65 3.59 -140.19
Enterprise Value
EV to EBITDA
-46.16 10.60 1.65 3.59 -140.19
EV to Sales
6.16 3.02 1.18 2.84 30.55
EV to Free Cash Flow
-69.28 2.47 1.55 73.30 -148.95
EV to Operating Cash Flow
81.59 2.15 1.51 60.61 -1.09K
Tangible Book Value Per Share
75.87 79.30 81.53 47.92 5.13
Shareholders’ Equity Per Share
80.75 84.15 82.43 48.74 5.83
Tax and Other Ratios
Effective Tax Rate
0.02 0.22 0.27 0.32 1.10
Revenue Per Share
11.44 15.87 71.15 77.77 2.05
Net Income Per Share
-2.77 3.87 38.78 42.18 0.06
Tax Burden
0.98 0.78 0.73 0.68 -0.10
Interest Burden
1.02 0.99 1.05 1.01 1.01
Research & Development to Revenue
0.82 0.47 <0.01 <0.01 1.34
SG&A to Revenue
0.19 0.13 0.03 0.01 0.19
Stock-Based Compensation to Revenue
0.04 0.01 <0.01 <0.01 0.07
Income Quality
-0.31 4.53 1.05 0.06 0.09
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis